🔎 Trials Near Me

Akèy › Kansè kolorektal › Distrik Columbia › Washington

Etid klinik pou Kansè kolorektal nan Washington, DC

29 etid pou Kansè kolorektal ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 45 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06995898

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT01915225

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 72 · Tout sèks · Mizajou Oct 2, 2026 · NCT01174121

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Ap rekrite
  • MedStar Health, Washington D.C.
Laj 65 a 82 · Tout sèks · Mizajou Oct 2, 2026 · NCT05612347

Evaluation for NCI Surgery Branch Clinical Research Protocols

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT00001823

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Ap rekriteFaz 2
  • George Washington University Medical Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Oct 1, 2026 · NCT05286814

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Ap rekriteFaz 1/2Mande peman pou patisipan yo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT06149481

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Ap rekriteFaz 1/2
  • Sibley Memorial Hospital ( Site 0310), Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06428409

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Ap rekriteFaz 3
  • Georgetown Univ Medical Center Lombardi Cancer Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06662786

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Ap rekriteFaz 2/3
  • Maryland Oncology Hematology - Silver Spring, Silver Spring · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07221357

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 12 a 120 · Tout sèks · Mizajou Sep 23, 2026 · NCT04222413

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Ap rekriteFaz 1/2
  • Georgetown University Lombardi Cancer Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Ap rekriteFaz 3
  • George Washington University, Washington D.C.
  • Cancer Center For Blood Disorders A Division of American Oncology Partners P.A, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07284849

Colorectal Cancer Screening in the Homeless

Ap rekrite
  • George Washington University, Washington D.C.
Laj 45 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07220018

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

Ap rekriteFaz 1/2
  • MedStar Georgetown University Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07147231

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Ap rekriteFaz 1
  • Georgetown University Medical Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07227168

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Ap rekriteFaz 1
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06586515

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Ap rekriteFaz 2
  • Research Site, Washington D.C.
Laj 18 a 130 · Tout sèks · Mizajou Aug 18, 2026 · NCT06792695

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Ap rekriteFaz 1/2
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT05691491

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cancer Support Community Research & Training Institute, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT02333604

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Ap rekriteEtid obsèvasyon
  • MedStar Georgetown University Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Jan 9, 2026 · NCT06073431

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Ap rekriteEtid obsèvasyon
  • MedStar Georgetown University Hospital, Washington D.C.
Laj 60 ak plis · Tout sèks · Mizajou Jan 8, 2026 · NCT03998202

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Ap rekriteEtid obsèvasyon
  • The Center for Cancer and Blood Disorders, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2025 · NCT05234177

Etid Kansè kolorektal nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.